Formatics 2009, 25(19):2522-2529. Svicher V, Sing T, Santoro MM, Forbici F, Rodr
Formatics 2009, 25(19):2522-2529. Svicher V, Sing T, Santoro MM, Forbici F, Rodr uez-Barrios F, Bertoli A, Beerenwinkel N, Bellocchi MC, Gago F, d’Arminio Monforte A, Antinori A, Lengauer T, Ceccherini-Silberstein F, Perno CF: Involvement of novel Human Immunodeficiency Virus type 1 reverse transcriptase mutations in the regulation of purchase Aviptadil Resistance to nucleoside inhibitors. J Virol 2006, 80(14):7186-7198. Arora P, Dixit NM: Timing the emergence of resistance to anti-HIV drugs with large genetic barriers. PLoS Comput Biol 2009, 5(3):e1000305. PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/28192408 Healy B, Degruttola V: Hidden Markov models for settings with intervalcensored transition times and uncertain time origin: application to HIV genetic analyses. Biostatistics 2007, 8(2):438-452. Deforche K, Camacho RJ, Grossman Z, Soares MA, Laethem KV, Katzenstein DA, Harrigan PR, Kan-tor R, Shafer R, Vandamme AM, non B Workgroup: Bayesian network analyses of resistance pathways against efavirenz and nevirapine. AIDS 2008, 22(16):2107-2115. Johnson VA, Brun-Vezinet F, Clotet B, Gunthard HF, Kuritzkes DR, Pillay D, Schapiro JM, Richman DD: Update of the Drug Resistance Mutations in HIV-1. Top HIV Med 2008, 16(5):138-145. Foulkes AS, DeGruttola PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/28607003 V: Characterizing the Progression of Viral Mutations Over Time. Journal of the American Statistical Association 2003, 98(464):859-867. JQ JF, Li R: Variable selection via nonconcave penalized likelihood and its oracle properties. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION 2001, 96(456):1348-1360. Rosen-Zvi M, Altmann A, Prosperi M, Aharoni Neuvirth H, S nerborg A, Sch ter E, Struck D, Peres Y, Incardona F, Kaiser R, Zazzi M, Lengauer T: Selecting anti-HIV therapies based on a variety of genomic and clinical factors. Bioinfor-matics 2008, 24(13):i399-406[http://bioinformatics. oxfordjournals.org/cgi/content/full/24/13/i399]. R Development Core Team: R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria 2004 [http://www.R-project.org], [ISBN 3-900051-00-3]. Fan J, Feng Y, Samworth R, Wu Y: SIS: Sure Independence Screening 2010, [R package version 0.6]. Therneau T, original R port by Thomas Lumley: survival: Survival analysis, including penalised likelihood 2009 [http://r-forge.r-project.org], [R package version 2.35-8]. Wickham H: ggplot2: elegant graphics for data analysis. Springer New York 2009 [http://had.co.nz/ggplot2/book]. Csardi G, Nepusz T: The igraph software package for complex network research. InterJournal 2006, Complex Systems:1695[http://igraph.sf.net]. Brehm JH, Koontz D, Meteer JD, Pathak V, Sluis Cremer N, Mellors JW: Selection of mutations in the connection and RNase H domains of Human Immunodeficiency Virus type 1 reverse transcriptase that increase resistance to 3′-azido-3′-dideoxythymidine. J Virol 2007, 81(15):7852-7859. Sing T, Svicher V, Beerenwinkel N, Ceccherini-Silberstein F, D mer M, Kaiser R, Walter H, Korn K, Hoffmann D, Oette M, Rockstroh JK, F kenheuer G, Perno CF, Lengauer T: Characterization of Novel HIV Drug Resistance Mutations Using Clustering, Multidimensional Scaling and SVM-Based Feature Ranking. In Knowledge Discovery in Databases: PKDD 2005, Volume 3721 of Lecture Notes in Computer Science. Edited by: Jorge A, Torgo L, Brazdil P, Camacho R, Gama J. Springer; 2005:285-296. D mer M, Awerkiew S, Arag SS, Kartashev Poplavskaja T, Klein R, Sichtig N, Thiele B, Lengauer T, Roomp K, Pfister H, Kaiser R: Short communication: selection of thymidine analogue resistance.
